Litigation Details for SUPERNUS PHARMACEUTICALS, INC. v. APOTEX INC. (D.N.J. 2020)
✉ Email this page to a colleague
SUPERNUS PHARMACEUTICALS, INC. v. APOTEX INC. (D.N.J. 2020)
| Docket | ⤷ Try a Trial | Date Filed | 2020-06-26 |
| Court | District Court, D. New Jersey | Date Terminated | 2023-06-27 |
| Cause | 15:1126 Patent Infringement | Assigned To | Michael Andre Shipp |
| Jury Demand | None | Referred To | Tonianne J. Bongiovanni |
| Parties | APOTEX CORP. | ||
| Patents | 10,220,042; 7,722,898; 7,910,131; 8,617,600; 8,821,930; 9,119,791; 9,351,975; 9,370,525; 9,855,278 | ||
| Attorneys | ARNOLD B. CALMANN | ||
| Firms | Haug Partners LLP, Ny | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in SUPERNUS PHARMACEUTICALS, INC. v. APOTEX INC.
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for SUPERNUS PHARMACEUTICALS, INC. v. APOTEX INC. (D.N.J. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-06-26 | 1 | Complaint | 9,855,278 (“the ’278 patent”), and United States Patent No. 10,220,042 (“the ’042 patent”), attached hereto…’898 patent, the ’131 patent, the ’600 patent, the ’930 patent, the ’791 patent, the ’975 patent, the…the ’131 patent”), United States Patent No. 8,617,600 (“the ’600 patent”), United States Patent No. 8,821,930…the ’930 patent”), United States Patent No. 9,119,791 (“the ’791 patent”), United States Patent No. 9,351,975…PageID: 2 patent”), United States Patent No. 9,370,525 (“the ’525 patent), United States Patent No. 9,855,278 | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
